Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02.

Peters LJ, O'Sullivan B, Giralt J, Fitzgerald TJ, Trotti A, Bernier J, Bourhis J, Yuen K, Fisher R, Rischin D.

J Clin Oncol. 2010 Jun 20;28(18):2996-3001. doi: 10.1200/JCO.2009.27.4498. Epub 2010 May 17.

PMID:
20479390
2.

DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer.

Iacobuzio-Donahue CA, Fu B, Yachida S, Luo M, Abe H, Henderson CM, Vilardell F, Wang Z, Keller JW, Banerjee P, Herman JM, Cameron JL, Yeo CJ, Halushka MK, Eshleman JR, Raben M, Klein AP, Hruban RH, Hidalgo M, Laheru D.

J Clin Oncol. 2009 Apr 10;27(11):1806-13. doi: 10.1200/JCO.2008.17.7188. Epub 2009 Mar 9.

3.

Squamous cell carcinoma of the anal canal: utilization and outcomes of recommended treatment in the United States.

Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti MS, Halverson AL.

Ann Surg Oncol. 2008 Jul;15(7):1948-58. doi: 10.1245/s10434-008-9905-2. Epub 2008 Apr 15.

PMID:
18414951
4.

Processes for quality improvements in radiation oncology clinical trials.

FitzGerald TJ, Urie M, Ulin K, Laurie F, Yorty J, Hanusik R, Kessel S, Jodoin MB, Osagie G, Cicchetti MG, Pieters R, McCarten K, Rosen N.

Int J Radiat Oncol Biol Phys. 2008;71(1 Suppl):S76-9. doi: 10.1016/j.ijrobp.2007.07.2387.

5.

Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial.

Regine WF, Winter KA, Abrams RA, Safran H, Hoffman JP, Konski A, Benson AB, Macdonald JS, Kudrimoti MR, Fromm ML, Haddock MG, Schaefer P, Willett CG, Rich TA.

JAMA. 2008 Mar 5;299(9):1019-26. doi: 10.1001/jama.299.9.1019. Erratum in: JAMA. 2008 Apr 23/30;299(16):1902.

PMID:
18319412
6.

Quality control of involved field radiotherapy in patients with early-favorable (HD10) and early-unfavorable (HD11) Hodgkin's lymphoma: an analysis of the German Hodgkin Study Group.

Eich HT, Engenhart-Cabillic R, Hansemann K, Lukas P, Schneeweiss A, Seegenschmiedt H, Skripnitchenko R, Staar S, Willich N, Müller RP.

Int J Radiat Oncol Biol Phys. 2008 Aug 1;71(5):1419-24. doi: 10.1016/j.ijrobp.2007.12.002. Epub 2008 Jan 30.

PMID:
18234433
7.

Comment on "adjuvant therapy in pancreatic cancer: a critical appraisal".

Abrams RA.

Drugs. 2007;67(17):2481-5; discussion 2491-3. Review. No abstract available.

PMID:
18034585
8.

Adjuvant therapy in pancreatic cancer: a critical appraisal.

Oettle H, Neuhaus P.

Drugs. 2007;67(16):2293-310. Review.

PMID:
17983252
9.

Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial.

Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, Ridwelski K, Schramm H, Fahlke J, Zuelke C, Burkart C, Gutberlet K, Kettner E, Schmalenberg H, Weigang-Koehler K, Bechstein WO, Niedergethmann M, Schmidt-Wolf I, Roll L, Doerken B, Riess H.

JAMA. 2007 Jan 17;297(3):267-77.

PMID:
17227978
10.

Significant regional variation in adequacy of lymph node assessment and survival in gastric cancer.

Coburn NG, Swallow CJ, Kiss A, Law C.

Cancer. 2006 Nov 1;107(9):2143-51.

11.

Changing the patterns of failure for high-risk prostate cancer patients by optimizing local control.

Stock RG, Ho A, Cesaretti JA, Stone NN.

Int J Radiat Oncol Biol Phys. 2006 Oct 1;66(2):389-94.

PMID:
16965991
12.

Compliance to clinical guidelines for early-stage epithelial ovarian cancer in relation to patient outcome.

Sijmons EA, van Lankveld MA, Witteveen PO, Peeters PH, Koot VC, van Leeuwen JS.

Eur J Obstet Gynecol Reprod Biol. 2007 Apr;131(2):203-8. Epub 2006 May 16.

PMID:
16707204
13.

Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials.

Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans V, Godwin J, Gray R, Hicks C, James S, MacKinnon E, McGale P, McHugh T, Peto R, Taylor C, Wang Y; Early Breast Cancer Trialists' Collaborative Group (EBCTCG)..

Lancet. 2005 Dec 17;366(9503):2087-106. Review.

14.

Audit of the radiotherapy in the DBCG 82 b&c trials--a validation study of the 1,538 patients randomised to postmastectomy radiotherapy.

Nielsen HM, Overgaard J, Grau C, Christensen JJ, Overgaard M.

Radiother Oncol. 2005 Sep;76(3):285-92.

PMID:
16150503
15.

A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer.

Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, Hickey H, Beger H, Fernandez-Cruz L, Dervenis C, Lacaine F, Falconi M, Pederzoli P, Pap A, Spooner D, Kerr DJ, Büchler MW; European Study Group for Pancreatic Cancer..

N Engl J Med. 2004 Mar 18;350(12):1200-10. Erratum in: N Engl J Med. 2004 Aug 12;351(7):726.

16.

Compliance with acute MI guidelines lowers inpatient mortality.

Szekendi MK; American College of Cardiology.; American Heart Association..

J Cardiovasc Nurs. 2003 Nov-Dec;18(5):356-9. Review.

PMID:
14680338
17.

Early reversal of pediatric-neonatal septic shock by community physicians is associated with improved outcome.

Han YY, Carcillo JA, Dragotta MA, Bills DM, Watson RS, Westerman ME, Orr RA.

Pediatrics. 2003 Oct;112(4):793-9. Review.

PMID:
14523168
18.

Early use of glycoprotein IIb/IIIa inhibitors in non-ST-elevation acute myocardial infarction: observations from the National Registry of Myocardial Infarction 4.

Peterson ED, Pollack CV Jr, Roe MT, Parsons LS, Littrell KA, Canto JG, Barron HV; National Registry of Myocardial Infarction (NRMI) 4 Investigators..

J Am Coll Cardiol. 2003 Jul 2;42(1):45-53.

19.

The mechanism of action of radiosensitization of conventional chemotherapeutic agents.

Lawrence TS, Blackstock AW, McGinn C.

Semin Radiat Oncol. 2003 Jan;13(1):13-21. Review.

PMID:
12520460
20.

Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N.

N Engl J Med. 2002 Oct 17;347(16):1233-41.

Supplemental Content

Support Center